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The online version has been updated to correct an error in Table 1. Table 1.Patient characteristics of all patients and the propensity score-matched cohortAll (*n* = 1282)Propensity score 2:1 matched (*n* = 735)ESWLURSP-valueESWLURSP-valueNumber of patients (%)999 (78)283 (22)490 (67)245 (33)Age, years (±SD)49 (15.0)51 (14.4)0.12450 (15.0)51 (14.2)0.685Female (%)274 (27.4)74 (26.1)0.669126 (25.7)71 (29.0)0.346Male (%)725 (72.6)209 (73.9)364 (74.3)174 (71.0)BMI, kg/m~2~ (±SD)27 (4.75)27 (4.64)0.59627 (4.4)27 (4.9)0.790Size of biggest stone, mm (IQR)9 (7--11)8 (6--11)**\<0.001**8 (6--10)8 (6--12)0.988Number of stones (%)**\<0.001**0.722 149515758 215252622 37131111 \>341159Complications (%) Clavien II24 (2.4)20 (7.1)**\<0.001**17 (3.5)17 (6.9)**\<0.001** Clavien IIIa8 (0.8)0 (0)0.213 (0.6)0 (0) Clavien IIIb5 (0.5)1 (0.4)0.303 (0.6)1 (0.4) Clavien IV000 (0)0 (0)[^1]

has been changed to Table 1.Patient characteristics of all patients and the propensity score-matched cohortAll (*n* = 1282)Propensity score 2:1 matched (*n* = 735)ESWLURSP-valueESWLURSP-valueNumber of patients (%)999 (78)283 (22)490 (67)245 (33)Age (±SD)49.4 (15.0)50.9 (14.4)0.12450.1 (15.0)50.7 (14.2)0.685Female (%)274 (27.4)74 (26.1)0.669126 (25.7)71 (29.0)0.346Male (%)725 (72.6)209 (73.9)364 (74.3)174 (71.0)BMI (±SD)26.74 (4.75)26.56 (4.64)0.59626.6 (4.4)26.7 (4.9)0.790Size of biggest stone, in mm (IQR)9 (7--11)8 (6--11)**\<0.001**8 (6--10)8 (6--12)0.988Number of stones 1 stone74.8%50.7%**\<0.001**57.0%57.6%0.722 2 stones15.1%25.3%26.3%22.2% 3 stones6.6%13.3%11.3%11.1% \>3 stones3.5%10.7%5.4%9.1%Complications (%) Clavien II24 (2.4)20 (7.1)**\<0.001**17 (3.5)17 (6.9)**\<0.001** Clavien IIIa8 (0.8)0 (0)0.213 (0.6)0 (0) Clavien IIIb5 (0.5)1 (0.4)0.303 (0.6)1 (0.4) Clavien IV000 (0)0 (0)[^2]

[^1]: Bold P-values indicate statistical significance.

[^2]: Bold P-values indicate statistical significance.
